C21H19FN6O2
406.4 g/mol
APIWarning
Lorlatinib
CAS1454846-35-5
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Lorlatinib is an active pharmaceutical ingredient used in the manufacture of medications for non-small cell lung cancer. It acts as an inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1), making it a compound for targeted cancer research and pharmaceutical production.
pharmaceutical manufacturingtargeted cancer researchALK/ROS1 inhibitor development
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1454846-35-5
Related Compounds
ReferenceSame Category
Dasabuvir sodium hydrate
CAS1456607-55-8
pharmaceutical raw material
ReferenceSame Category
Paritaprevir dihydrate
CAS1456607-71-8
pharmaceutical raw material
ReferenceSame Category
Cetrotide
CAS145672-81-7
pharmaceutical raw material
ReferenceSame Category
Phenyl (3R,4R)-4-(3-isopropoxyphenyl)-3,4-dimethylpiperidine-1-carboxylate
CAS145678-86-0
pharmaceutical raw material
Safety Reference
Warning
H341Suspected of causing genetic defects
H361Suspected of damaging fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name
(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile
InChIKey
IIXWYSCJSQVBQM-LLVKDONJSA-N
SMILES
C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C
Synonyms (21)
- Lorlatinib (JAN/USAN/INN)
- 4cli
- 4clj
- Loratinib
- Lorbrena
- Lorbrena (TN)
- Lorlatinib
- Lorlatinib (PF-06463922)
- Lorlatinib (Standard)
- Lorviqua
- PF06463922(Lorlatinib)
- PFE-PKIS 10
- lorlatinibum